Medpace builds up in Scotland; Chinese CRO market primed to pop, report says;

> Medpace has tripled the size of its outpost in Scotland, adding a new office to focus on data management, biostatistics and regulatory affairs. More

> The Chinese CRO market will grow to $13.6 billion in 2018 from just $6.6 billion in 2014, according to a report from Research and Markets. Item

Suggested Articles

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.

Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.